Over the last 6 months PAA had both Michael & John in CEO and COO positions to deliver the activity set. Nothing has changed as far as deliverables go, in fact I expect the workload will only increase over the next 6 - 12 months.
So PharmAust will be needing to recruit.
But given the ASX release clearly has John as interim CEO, is the intention to hire a new CEO, with John in a caretaker role , returning to COO once the hire is complete.
If that is the case, PharmAust may well attract a high profile & high performing biotechnology CEO. The results to date, ODD designation … and the chance to lead commercialising a drug with a mechanism of action that may revolutionise care across neurodegenerative disease. Could be very tempting for the right high flyer.
Every problem creates an opportunity…
Let’s see how this pans out.
- Forums
- ASX - By Stock
- PAA
- Ann: Resignation of Dr Michael Thurn & appointment of John Clark
Ann: Resignation of Dr Michael Thurn & appointment of John Clark, page-234
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $81.16M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.5¢ | $87.97K | 426.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10300 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 261000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10300 | 0.205 |
11 | 338540 | 0.200 |
5 | 183692 | 0.195 |
13 | 276686 | 0.190 |
3 | 314594 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 261000 | 3 |
0.215 | 207775 | 6 |
0.220 | 239679 | 2 |
0.225 | 62500 | 1 |
0.240 | 40977 | 2 |
Last trade - 15.59pm 26/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |